Seven southern states account for 70% of U.S. orders for monoclonal antibodies, the treatment of choice for many vaccine refusals

by



[ad_1]



man standing in front of a curtain: Health workers work inside the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Fla. August 19, 2021. - Florida Governor Ron DeSantis announced the initiation of treatment with Covid-19 antibodies. DeSantis continues to promote monoclonal antibody treatments as cases and hospitalizations increase in Florida. Starting Wednesday, CB Smith Park will begin offering antibody therapy from 9 am to 5 pm seven days a week. The site will be able to treat more than 300 patients per day. Photo by Chandan Khanna / AFP via Getty Image


© Provided by INSIDER
Health workers work inside the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Fla., August 19, 2021. – Florida Governor Ron DeSantis announced the opening of the treatment site with Covid-19 antibody. DeSantis continues to promote monoclonal antibody treatments as cases and hospitalizations increase in Florida. Starting Wednesday, CB Smith Park will begin offering antibody therapy from 9 am to 5 pm seven days a week. The site will be able to treat more than 300 patients per day. Photo by Chandan Khanna / AFP via Getty Image

  • Orders for monoclonal antibody doses increased from 27,000 in July to 168,000 doses per week at the end of August.
  • Kentucky Gov. Andy Beshear said on Thursday the state was running low on pay.
  • Monoclonal antibody treatment for COVID-19 received FDA clearance in 2020.
  • Visit the Insider homepage for more stories.

70% of orders placed for doses of monoclonal antibodies came from seven southern states, where governors frequently promote the expensive treatment as part of their COVID-19 strategy, according to the New York Times.

As orders grew from 27,000 in July to 168,000 doses per week at the end of August, the Biden administration has called on states to prepare for the dwindling domestic supply of treatment and expect reduced shipments. due to growing demand from less vaccinated southern states, the Times reported.

Gallery: CDC and FDA just issued warning on this type of marijuana (better life)

a close-up of a green plant: Over the past 25 years, the United States has seen a major overhaul in the way we think about and regulate the use of marijuana. In 1996 California became the first state to approve medical marijuana, and in 2012 Colorado and Washington became the first to legalize it for recreational use. Since then, we've seen a cascade of new legislatures surrounding cannabis: today, 18 US states plus Washington, DC have legalized marijuana for adults over 21, and 37 states have legalized marijuana for medical purposes. for those with approved health conditions; however, some health authorities have expressed concerns about the increasing availability of the drug. In fact, the US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) just issued a warning about a particular type of marijuana, which they say could put you at unexpected risk. of tetrahydrocannabinol (THC) intoxication and more. Read on to find out what type of marijuana the CDC and FDA are sounding the alarm bells for and how to recognize a problem. RELATED: It Is The State With The Most Marijuana Users, Data Shows. Read the original article on Best Life.

Several states, including Missouri, Texas and Florida, have expanded access to monoclonal antibody treatment in recent weeks, although each of their governors opposes the vaccine and mask mandates.

“We’re going to be at a point in a week’s time where there will be people who want and probably need this treatment and we won’t get enough of it,” Kentucky Gov. Andy Beshear said Thursday, according to WLWT .

Monoclonal antibodies are proteins made in the lab that mimic the immune system’s ability to fight off harmful antigens such as viruses, according to the Food and Drug Administration (FDA). The treatment, which is no less experimental than COVID-19 vaccines, received FDA clearance in 2020.

Read the original article on Insider

[ad_2]

Source link